BioMarin Pharmaceutical (BMRN)
(Delayed Data from NSDQ)
$69.13 USD
-1.56 (-2.21%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $69.01 -0.12 (-0.17%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 32% (80 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.48 | 1.38 | 9.99 |
Current Quarter Estimate | 0.79 | 3.11 | 61.00 |
Year Ago Quarter Estimate | 0.46 | -4.81 | 54.84 |
Next Quarter Estimate | 0.81 | 3.91 | 63.00 |
Next Year Estimate | 4.06 | 24.92 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 56.25 | 17.30 | 15.67 |
Next Year | 24.92 | 10.10 | 11.34 |
Last 5 Years | NA | 0.90 | 8.10 |
Next 5 Years | 36.10 | 22.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 26.39 | -6.90 |
Price/Book (MRQ) | 2.48 | 2.05 |
Price/Cash Flow (MRFY) | 38.64 | 16.44 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 9.91% | -154.18% |
Return on Equity (TTM) | 6.91% | -61.34% |
Debt to Equity (MRQ) | 0.11 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.